| Ytd | -2.52% | |
| 1y | -15.06% |
| Open | 92.84 | Prev Close | 92.80 | Low | 92.04 | High | 93.22 | Mkt Cap | 23.31B |
| Vol | 685.89K | Avg Vol | 955.30K | EPS | -5.53 | P/E | -16.79 | Forward P/E | -16.51 |
| Beta | 1.28 | Short Ratio | 2.73 | Inst. Own | 20.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 06-02 | Earning | 08-04 | 50-d Avg | 91.37 | 200-d Avg | 97.82 | 1yr Est | 120.38 |
https://youtu.be/H_RititNE8U
Bank of New York Mellon Corp lowered its holdings in BioNTech SE Sponsored ADR (NASDAQ: BNTX) by 64.
BioNTech SE (BNTX) Q2 2026 Earnings Call Transcript
BioNTech NASDAQ: BNTX reported second-quarter 2026 revenue of €106 million, down from €261 million a
Pfizer beats earnings forecasts for the second quarter, while BioNTech's results miss expectations d
German vaccine maker BioNTech lowered its full year sales outlook range on Tuesday due to softer
Guido Oelkers, Ph.D., appointed to BioNTech Management Board as Chief Executive Officer , taking off
German biotech firm BioNTech said on Monday that Sobi's CEO Guido Oelkers will succeed Ugur Sahi
Mainz, Germany, August 3, 2026 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Comp
BioNTech trades near cash value, implying its advanced oncology pipeline is valued at nearly zero—an
The formula targets the XFG variant, for active immunization to prevent COVID-19 caused by SARS-CoV-
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasda
Data indicate that the 2026-2027 COVID-19 vaccine formula, targeting the XFG variant, induces a stro
Rep. Thomas Massie questions JD Vance's silence after the Trump CDC established a $1.24 Billion
BioNTech's oncology pipeline could help it make a dent in this large and growing market. However, th
MAINZ, Germany, July 21 , 2026 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Comp
Baader Bank Aktiengesellschaft lowered its stake in BioNTech SE Sponsored ADR (NASDAQ: BNTX) by 10.4
Amova Asset Management Americas Inc. acquired a new position in shares of BioNTech SE Sponsored ADR
Arbutus and its exclusive licensee, Genevant, filed three international lawsuits seeking to enforce
On July 8, the Ark Genomic Revolution ETF sold roughly $7.4 million worth of BioNTech stock. Cathie
They may not remain cheap for too much longer.
BioNTech has held confidential talks with potential buyers about the German sites that the COVID‑1
U.S. pharmaceutical company Moderna is interested in investing in production facilities in German
Arcus Biosciences teams up with Bristol Myers Squibb to test casdatifan combinations in kidney cance
https://www.nytimes.com/2026/05/05/us/politics/fda-covid-vaccine-studies.html
Dow falls 200+ points as Serve Robotics Inc (NASDAQ: SERV) shares rise 16.2% on better-than-expected
US stock futures lower, FreightCar America (RAIL) plunges after weak earnings. Other stocks moving l
Investors are anticipating earnings releases from Oracle, Ulta, Adobe, Dick's, AeroVironment and
Ten large-cap stocks led last week's gains, driven by upbeat earnings, guidance, buybacks, and k
Earnings misses, weak guidance, and downgrades drove large-cap decliners—led by Synopsys, Chewy, and
Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh
Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after t
Companies Reporting Before The Bell • UP Fintech Holding (NASDAQ:TIGR) is expected to report quarte
U.S. stock futures traded higher this morning, with the Dow Jones futures gaining more than 80 point
The beginning of the week brought mixed performance for stocks on Wall Street, with the major indice
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report quarterly loss a